The vulvar cancer drugs market is estimated to be valued at USD 0.640 Bn in 2024 and is expected to reach USD 1.131 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.47% from 2024 to 2031. https://www.zupyak.com/p/4487388/t/the-role-of-targeted-therapies-in-shaping-the-vulvar-cancer-drug-market